JCI - Citations to Replication-selective adenoviruses as oncolytic agents

Citations to this article

Replication-selective adenoviruses as oncolytic agents

Carla Heise, David H. Kirn

Carla Heise, David H. Kirn

Published April 1, 2000
Citation Information: J Clin Invest. 2000;105(7):847-851. https://doi.org/10.1172/JCI9762.

View: Text | PDF

Total citations by year

Year:	2025	2023	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1995	Total
Citations:	1	1	3	3	2	1	3	1	6	4	8	2	4	8	4	3	8	7	8	10	17	17	8	1	130

Citation information

Citations to this article (130)

Title and authors	Publication	Year
Harnessing State-of-the-Art Gene Therapy to Transform Oral Cancer Treatment. Zhang W, Zhang Y, Yang X, Chai H	Biochemical genetics	2025
Cancer immunotherapies: A hope for the uncurable? Hamdan F, Cerullo V		2023
Oncolytic Adenoviruses for Cancer Therapy L Tripodi, M Vitale, V Cerullo, L Pastore	International journal of molecular sciences	2021
Clinical Trials of Oncolytic Viruses in Breast Cancer. Carter ME, Koch A, Lauer UM, Hartkopf AD	Frontiers in Oncology	2021
Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein. Modi J, Roy A, Pradhan AK, Kumar A, Talukdar S, Bhoopathi P, Maji S, Mannangatti P, Sanchez De La Rosa D, Li J, Guo C, Subler MA, Windle JJ, Cavenee WK, Sarkar D, Wang XY, Das SK, Emdad L, Fisher PB	International journal of molecular sciences	2021
Oncolytic effect of Midkine promoter–based conditionally replicating adenoviruses expressing EGFR siRNA in head and neck squamous cancer cell line T891 N Uehara, N Otsuki, M Kubo, J Kitamoto, Y Kojima, M Teshima, H Shinomiya, T Shirakawa, K Nibu	EMBO reports	2020
Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer Cells E Ehrke-Schulz, S Heinemann, L Schulte, M Schiwon, A Ehrhardt	Cancers	2020
Identification of oncolytic vaccinia restriction factors in canine high-grade mammary tumor cells using single-cell transcriptomics B Cambien, K Lebrigand, A Baeri, N Nottet, C Compin, A Lamit, O Ferraris, CN Peyrefitte, V Magnone, J Henriques, LE Zaragosi, S Giorgetti-Peraldi, F Bost, M Gautier-Isola, R Rezzonico, P Barbry, R Barthel, B Mari, G Vassaux, E Bartee	PLoS pathogens	2020
Oncolytic adenoviruses: a game changer approach in the battle between cancer and the immune system V Cervera-Carrascon, R Havunen, A Hemminki	Expert Opinion on Biological Therapy	2019
Physically crosslinked injectable hydrogels for long-term delivery of oncolytic adenoviruses for cancer treatment TM Le, BK Jung, Y Li, HT Duong, TL Nguyen, JW Hong, CO Yun, DS Lee	Biomaterials Science	2019
Cancer terminator viruses ( CTV ): A better solution for viral-based therapy of cancer L Emdad, SK Das, XY Wang, D Sarkar, PB Fisher	Journal of Cellular Physiology	2018
Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents JD Papa, R Parks	Viruses	2017
Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas BC Kerrigan, Y Shimizu, M Andreeff, FF Lang	Cytotherapy	2017
Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent P Wang, X Li, J Wang, D Gao, Y Li, H Li, Y Chu, Z Zhang, H Liu, G Jiang, Z Cheng, S Wang, J Dong, B Feng, LS Chard, NR Lemoine, Y Wang	Nature Communications	2017
Interleukin-12-expressing oncolytic virus: A promising strategy for cancer immunotherapy AA Alkayyal, AB Mahmoud, RC Auer	Journal of Taibah University Medical Sciences	2016
Conditionally replicating oncolytic adenoviral vector expressing arresten and tumor necrosis factor-related apoptosis-inducing ligand experimentally suppresses lung carcinoma progression S Li, Z Qi, H Li, J Hu, D Wang, X Wang, Z Feng	Molecular medicine reports	2015
Oncolytic viruses: From bench to bedside with a focus on safety PR Buijs, JH Verhagen, CH van Eijck, BG van Hoogen	Human Vaccines & Immunotherapeutics	2015
Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1 K Li, H Zhang, J Qiu, Y Lin, J Liang, X Xiao, L Fu, F Wang, J Cai, Y Tan, W Zhu, W Yin, B Lu, F Xing, L Tang, M Yan, J Mai, Y Li, W Chen, P Qiu, X Su, G Gao, PW Tai, J Hu, G Yan	Molecular Therapy	2015
pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis JW Choi, SJ Jung, D Kasala, JK Hwang, J Hu, YH Bae, CO Yun	Journal of Controlled Release	2015
The targeted inhibitory effects of human amniotic fluid stem cells carrying CXCR4 promoter and DAL-1 on non-small cell lung carcinoma growth L Li, S Li, T Cai, H Wang, X Xie, Z Liu, Y Zhang	Gene Therapy	2015
Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic CJ Breitbach, K Parato, J Burke, TH Hwang, JC Bell, DH Kirn	Current Opinion in Virology	2015
Cancer-Causing Viruses and Their Inhibitors J Yasunaga	Cancer-Causing Viruses and Their Inhibitors	2014
Oncoapoptotic Markers in Oral Cancer: Prognostics and Therapeutic Perspective A Jain, S Bundela, RP Tiwari, PS Bisen	Molecular diagnosis & therapy	2014
Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro L Wang, Y Zhang, J Zhao, E Xiao, J Lu, S Fu, Z Wang	Tumor Biology	2014
Terapia génica citotóxica para el tratamiento del cáncer cerebral MA Ayala, M Candolfi	Neurología Argentina	2014
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer J Heo, T Reid, L Ruo, CJ Breitbach, S Rose, M Bloomston, M Cho, HY Lim, HC Chung, CW Kim, J Burke, R Lencioni, T Hickman, A Moon, YS Lee, MK Kim, M Daneshmand, K Dubois, L Longpre, M Ngo, C Rooney, JC Bell, BG Rhee, R Patt, TH Hwang, DH Kirn	Nature Medicine	2013
Fiber-substituted Conditionally Replicating Adenovirus Ad5F35 Induces Oncolysis of Human Bladder Cancer Cells in In Vitro Analysis A Gotoh, H Nagaya, T Kanno, M Tagawa, T Nishizaki	Urology	2013
Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy JW Choi, E Kang, OJ Kwon, TJ Yun, HK Park, PH Kim, SW Kim, JH Kim, CO Yun	Gene Therapy	2013
Current status of local therapy in malignant gliomas — A clinical review of three selected approaches TA Juratli, G Schackert, D Krex	Pharmacology & Therapeutics	2013
Experimental studies on treatment of pancreatic cancer with double-regulated duplicative adenovirus AdTPHre-hEndo carrying human endostatin gene Y Shan, Y Fang, X Wang, R Jin, Q Zhang, R Andersson	Pancreatology	2013
An overview of gene therapy in head and neck cancer A Bali, D Bali, A Sharma	Indian journal of human genetics	2013
MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver E Ylösmäki, S Lavilla-Alonso, S Jäämaa, M Vähä-Koskela, T Hällström, A Hemminki, J Arola, H Mäkisalo, K Saksela	PloS one	2013
MicroRNA-Mediated Suppression of Oncolytic Adenovirus Replication in Human Liver E Ylösmäki, S Lavilla-Alonso, S Jäämaa, M Vähä-Koskela, T Hällström, A Hemminki, J Arola, H Mäkisalo, K Saksela, KT Jeang	PloS one	2013
Advances in Cancer Research SK Das, S Sarkar, R Dash, P Dent, XY Wang, D Sarkar, PB Fisher	Advances in cancer research	2012
Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer model LJ Gamble, H Ugai, M Wang, AV Borovjagin, QL Matthews		2012
Clinical development of experimental therapies for malignant glioma NG Rainov, V Heidecke	Sultan Qaboos University medical journal	2011
Oncolytic adenovirus armed with human papillomavirus E2 gene in combination with radiation demonstrates synergistic enhancements of antitumor efficacy W Wang, X Xia, S Wang, N Sima, Y Li, Z Han, Q Gao, A Luo, K Li, L Meng, J Zhou, C Wang, K Shen, D Ma	Cancer Gene Therapy	2011
Effects of nanoparticle coatings on the activity of oncolytic adenovirus–magnetic nanoparticle complexes N Tresilwised, P Pithayanukul, PS Holm, U Schillinger, C Plank, O Mykhaylyk	Biomaterials	2011
A Novel CRAd in Combination With Cisplatin Enhanced the Antitumor Efficacy in Ovarian Cancer : B Zhang, Y Liu, P Zhang, Y Wei, X Yin, J Zheng	International Journal of Gynecological Cancer	2011
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
Fiber mediated receptor masking in non-infected bystander cells restricts adenovirus cell killing effect but promotes adenovirus host co-existence J Rebetz, M Na, C Su, B Holmqvist, A Edqvist, C Nyberg, B Widegren, LG Salford, HO Sjögren, N Arnberg, Q Qian, X Fan	PloS one	2009
Gene therapy of benign gynecological diseases MH Hassan, EE Othman, D Hornung, A Al-Hendy	Advanced Drug Delivery Reviews	2009
Potent antitumor activity of double-regulated oncolytic adenovirus-mediated ST13 for colorectal cancer DB Yu, SY Zhong, M Yang, YG Wang, QJ Qian, S Zheng, XY Liu	Cancer Science	2009
Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks M Arendt, L Nasir, IM Morgan	Veterinary and Comparative Oncology	2009
Fiber Mediated Receptor Masking in Non-Infected Bystander Cells Restricts Adenovirus Cell Killing Effect but Promotes Adenovirus Host Co-Existence J Rebetz, M Na, C Su, B Holmqvist, A Edqvist, C Nyberg, B Widegren, LG Salford, HO Sjögren, N Arnberg, Q Qian, X Fan, MG Masucci	PloS one	2009
Reproductive Endocrinology PJ Chedrese		2009
Potent antitumor activity of double‐regulated oncolytic adenovirus‐mediated ST13 for colorectal cancer Yu DB, Zhong SY, Yang M, Wang YG, Qian QJ, Zheng S, Liu XY	Cancer Science	2009
Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy KF Hsu, CL Wu, SC Huang, JL Hsieh, YS Huang, YF Chen, MR Shen, WJ Chung, CY Chou, AL Shiau	Cancer Gene Therapy	2008
Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA JN Zheng, DS Pei, LJ Mao, XY Liu, DD Mei, BF Zhang, Z Shi, RM Wen, XQ Sun	Cancer Gene Therapy	2008
Replication competent Semliki Forest virus prolongs survival in experimental lung cancer AM Määttä, K Mäkinen, A Ketola, T Liimatainen, FN Yongabi, M Vähä-Koskela, R Pirinen, O Rautsi, R Pellinen, A Hinkkanen, J Wahlfors	International Journal of Cancer	2008
Principles of Molecular Oncology MH Bronchud, MA Foote, G Giaccone, O Olopade, P Workman		2008
Carboxypeptidase G2-based gene-directed enzyme–prodrug therapy: a new weapon in the GDEPT armoury D Hedley, L Ogilvie, C Springer	Nature Reviews Cancer	2007
Midkine Promoter-Based Conditionally Replicative Adenovirus for Targeting Midkine-Expressing Human Bladder Cancer Model S Terao, T Shirakawa, S Kubo, A Bishunu, SJ Lee, K Goda, M Tsukuda, K Hamada, M Tagawa, A Takenaka, M Fujisawa, A Gotoh	Urology	2007
p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro HC Zhao, Q Zhang, Y Yang, MQ Lu, H Li, C Xu, GH Chen	World journal of gastroenterology : WJG	2007
Pharmacodynamics of non-replicating viruses, bacteriocins and lysins JJ Bull, RR Regoes	Proceedings. Biological sciences / The Royal Society	2006
Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak I Schuffenecker, I Iteman, A Michault, S Murri, L Frangeul, MC Vaney, R Lavenir, N Pardigon, JM Reynes, F Pettinelli, L Biscornet, L Diancourt, S Michel, S Duquerroy, G Guigon, MP Frenkiel, AC Bréhin, N Cubito, P Desprès, F Kunst, FA Rey, H Zeller, S Brisse	PLoS Medicine	2006
Oncolytic adenovirus-mediated transfer of the antisense chk2 selectively inhibits tumor growth in vitro and in vivo G Chen, J Zhou, Q Gao, X Huang, K Li, L Zhuang, M Huang, G Xu, S Wang, Y Lu, D Ma	Cancer Gene Therapy	2006
Telomeres and telomerase as targets for anticancer drug development KA Olaussen, K Dubrana, J Domont, JP Spano, L Sabatier, JC Soria	Critical Reviews in Oncology/Hematology	2006
Gene therapy developments for pancreatic cancer M Bhattacharyya, NR Lemoine	Best Practice & Research Clinical Gastroenterology	2006
A Phase I Trial of Intravenous CG7870, a Replication-Selective, Prostate-Specific Antigen–Targeted Oncolytic Adenovirus, for the Treatment of Hormone-Refractory, Metastatic Prostate Cancer EJ Small, MA Carducci, JM Burke, R Rodriguez, L Fong, L Ummersen, DC Yu, J Aimi, D Ando, P Working, D Kirn, G Wilding	Molecular Therapy	2006
Gene therapy and uterine leiomyoma: a review A Al-Hendy, S Salama	Human Reproduction Update	2006
Drug Discovery and Delivery in the 21st Century DJ Triggle	Medical Principles and Practice	2006
Oncolysis of human ovarian cancers by echovirus type 1 DR Shafren, D Sylvester, ES Johansson, IG Campbell, RD Barry	International Journal of Cancer	2005
Selective Induction of Apoptosis in Melanoma Cells by Tyrosinase Promoter-Controlled CD95 Ligand Overexpression LF Fecker, CC Geilen, AM Hossini, C Schwarz, H Fechner, DL Bartlett, CE Orfanos, J Eberle	Journal of Investigative Dermatology	2005
Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma B Geoerger, VW van Beusechem, P Opolon, J Morizet, L Laudani, Y Lecluse, M Barrois, S Idema, J Grill, WR Gerritsen, G Vassal	The Journal of Gene Medicine	2005
Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression T Pipiya, H Sauthoff, YQ Huang, B Chang, J Cheng, S Heitner, S Chen, WN Rom, JG Hay	Gene Therapy	2005
Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy DA Heideman, RM Overmeer, VW van Beusechem, WH Lamers, TB Hakvoort, PJ Snijders, ME Craanen, GJ Offerhaus, CJ Meijer, WR Gerritsen	Cancer Gene Therapy	2005
The present and future for gene and viral therapy of directly accessible prostate and squamous cell cancers of the head and neck JS Norris, KL Norris, DH Holman, A El-Zawahry, TE Keane, J Dong, M Tavassoli	Future Oncology	2005
Molecular Basis of Thyroid Cancer NR Farid		2005
Tissue-specific promoters for cancer gene therapy K Saukkonen, A Hemminki	Expert Opinion on Biological Therapy	2004
Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murineendostatin in hepatocellular carcinoma G Li, J Sham, J Yang, C Su, H Xue, D Chua, L Sun, Q Zhang, Z Cui, M Wu, Q Qian	International Journal of Cancer	2004
Insertion of an exogenous promoter in the E1A regulatory region of adenovirus does not disturb viral replication despite reduced E1A transcription L Yu, K Hamada, M Namba, K Kadomatsu, T Muramatsu, S Matsubara, M Tagawa	Cancer Letters	2004
Development of a novel recombinant adenovirus containing gfp–zeocin fusion expression cassette for conditional replication in p53-deficient human tumor cells B Hu, MN Joshua, C Dong, Y Qi	Journal of Virological Methods	2004
Diagnosis and Management of Ovarian Disorders AB Copperman, T Mukherjee, NG Kase	Diagnosis and Management of Ovarian Disorders	2004
Viral Therapy of Human Cancers: Improving Natural Oncolytic Properties by Genetic Engineering C Springfeld, A Fielding, KW Peng, E Galanis, S Russell, R Cattaneo	Viral Therapy of Human Cancers: Improving Natural Oncolytic Properties by Genetic Engineering	2004
An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency TC Liu, G Hallden, Y Wang, G Brooks, J Francis, N Lemoine, D Kirn	Molecular Therapy	2004
Adenoviruses: Model and Vectors in Virus-Host Interactions W Doerfler, P Böhm		2004
A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter M Tomizawa, L Yu, A Wada, T Tamaoki, K Kadomatsu, T Muramatsu, S Matsubara, K Watanabe, M Ebara, H Saisho, S Sakiyama, M Tagawa	British Journal of Cancer	2003
An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy ZL ZHANG, WG ZOU, CX LUO, BH LI, JH WANG, LY SUN, QJ QIAN, XY LIU	Cell Research	2003
Oncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model A Nawa, N Nozawa, F Goshima, T Nagasaka, F Kikkawa, Y Niwa, T Nakanishi, K Kuzuya, Y Nishiyama	Gynecologic Oncology	2003
Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system C Parada, JH Losa, J Guinea, V Sánchez-Arévalo, VF Soria, L Alvarez-Vallina, R Sánchez-Prieto, SR Cajal	Cancer Gene Therapy	2003
A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the α-fetoprotein promoter M Tomizawa, L Yu, A Wada, T Tamaoki, K Kadomatsu, T Muramatsu, S Matsubara, K Watanabe, M Ebara, H Saisho, S Sakiyama, M Tagawa	British Journal of Cancer	2003
Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model Y Nagayama, K Nakao, H Mizuguchi, T Hayakawa, M Niwa	Gene Therapy	2003
Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model VK Gupta, JO Park, T Kurihara, A Koons, HJ Mauceri, NT Jaskowiak, DW Kufe, RR Weichselbaum, MC Posner	Gene Therapy	2003
Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors VW van Beusechem, DC Mastenbroek, PB van Doel, ML Lamfers, J Grill, T Würdinger, HJ Haisma, HM Pinedo, WR Gerritsen	Gene Therapy	2003
54. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe HG Bender, P Dall		2003
Local Therapies for Glioma Present Status and Future Developments M Westphal, JC Tonn, Z Ram		2003
Encyclopedia of Cancer G Sgouros	Encyclopedia of Cancer	2002
Gene therapy for lung neoplasms SM Albelda, R Wiewrodt, DH Sterman	Clinics in Chest Medicine	2002
Adenoviruses in Oncology A Hemminki, RD Alvarez	BioDrugs	2002
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides KW Peng, S Facteau, T Wegman, D O'Kane, SJ Russell	Nature Medicine	2002
Differential Susceptibility of Pediatric Sarcoma Cells to Oncolysis by Conditionally Replication-Competent Herpes Simplex Viruses NS Bharatan, MA Currier, TP Cripe	Journal of Pediatric Hematology/Oncology	2002
Oncolytic Herpes Simplex Virus (G207) Therapy T Todo, MI Ebright, Y Fong, SD Rabkin		2002
Oncolytic Viruses LK Hawkins, D Kirn		2002
Reovirus Therapy of Ras-Associated Cancers PW Lee		2002
Adenoviral Vectors for Gene Therapy D Kirn	Adenoviral Vectors for Gene Therapy	2002
Gene Therapy of Cancer IV Lebedeva, CA Stein	Gene Therapy of Cancer	2002
Gene Therapy in Lung Disease K Amin	Gene Therapy in Lung Disease	2002
Cytolytic viruses as potential anti-cancer agents CJ Ring	Journal of General Virology	2002
Oncolytic biotherapy: a novel therapeutic plafform Lynda K Hawkins, Nick R Lemoine, David Kirn	The Lancet Oncology	2002
A System for Small-Molecule Control of Conditionally Replication-Competent Adenoviral Vectors H Chong, A Ruchatz, T Clackson, VM Rivera, RG Vile	Molecular Therapy	2002
Adenoviral Vectors with E1A Regulated by Tumor-Specific Promoters Are Selectively Cytolytic for Breast Cancer and Melanoma L Zhang, H Akbulut, Y Tang, X Peng, G Pizzorno, E Sapi, S Manegold, A Deisseroth	Molecular Therapy	2002
Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells MJ Savontaus, BV Sauter, TG Huang, SL Woo	Gene Therapy	2002
Manufacturing of Gene Therapeutics G Subramanian		2002
Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells S Taneja, J MacGregor, S Markus, S Ha, I Mohr	Proceedings of the National Academy of Sciences	2001
Wild-Type Adenovirus Decreases Tumor Xenograft Growth, but Despite Viral Persistence Complete Tumor Responses Are Rarely Achieved—Deletion of the Viral E1b-19-kD Gene Increases the Viral Oncolytic Effect D Harrison, H Sauthoff, S Heitner, J Jagirdar, WN Rom, JG Hay	Human Gene Therapy	2001
Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of Phase I and II trials D Kirn	Expert Opinion on Biological Therapy	2001
Gene therapy for high grade gliomas JB Alavi, SL Eck	Expert Opinion on Biological Therapy	2001
Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial T Reid, E Galanis, J Abbruzzese, D Sze, J Andrews, L Romel, M Hatfield, J Rubin, D Kirn	Gene Therapy	2001
Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region LK Hawkins, TW Hermiston	Gene Therapy	2001
Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region LK Hawkins, T Hermiston	Gene Therapy	2001
Oncolytic viruses and cancer therapy K L Norman, F Farassati, P W Lee	Cytokine & Growth Factor Reviews	2001
Variation in Adenovirus Receptor Expression and Adenovirus Vector-Mediated Transgene Expression at Defined Stages of the Cell Cycle MA Seidman, SM Hogan, RL Wendland, S Worgall, RG Crystal, PL Leopold	Molecular Therapy	2001
A Complex Adenovirus Vector That Delivers FASL–GFP with Combined Prostate-Specific and Tetracycline-Regulated Expression S Rubinchik, D Wang, H Yu, F Fan, M Luo, JS Norris, J Dong	Molecular Therapy	2001
Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy ES Lambright, K Amin, R Wiewrodt, SD Force, M Lanuti, KJ Propert, L Litzky, LR Kaiser, SM Albelda	Gene Therapy	2001
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? D Kirn	Gene Therapy	2001
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity J Nemunaitis, C Cunningham, A Buchanan, A Blackburn, G Edelman, P Maples, G Netto, A Tong, B Randlev, S Olson, D Kirn	Gene Therapy	2001
Intravascular injections of a conditional replicative adenovirus (adl118) prevent metastatic disease in human breast carcinoma xenografts A Fabra, C Parada, A Vinyals, PM Duque, V Fernandez, R Sanchez-Prieto, SR Cajal	Gene Therapy	2001
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics MA Kay, JC Glorioso, L Naldini	Nature Medicine	2001
Systemic therapy of myeloma xenografts by an attenuated measles virus KW Peng, GJ Ahmann, L Pham, PR Greipp, R Cattaneo, SJ Russell	Blood	2001
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice D Grote, SJ Russell, TI Cornu, R Cattaneo, R Vile, GA Poland, AK Fielding	Blood	2001
Prodrug-activating systems in suicide gene therapy CJ Springer, I Niculescu-Duvaz	Journal of Clinical Investigation	2000
Immunomodulation of cancer: potential use of selectively replicating agents S Agha-Mohammadi, MT Lotze	Journal of Clinical Investigation	2000
Regulatable systems: applications in gene therapy and replicating viruses S Agha-Mohammadi, MT Lotze	Journal of Clinical Investigation	2000
Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen T Kurihara, DE Brough, I Kovesdi, DW Kufe	Journal of Clinical Investigation	2000
Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice D Hanahan, G Bergers, E Bergsland	Journal of Clinical Investigation	2000
Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer T Hermiston	Journal of Clinical Investigation	2000
Conditionally replicative adenoviral vectors for cancer gene therapy J Gómez, DT Curiel	The Lancet Oncology	2000
Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer D Kirn	Oncogene	2000
Spatial and temporal control of gene therapy using ionizing radiation T Kurihara, DE Brough, I Kovesdi, DW Kufe	Nature Medicine	1995

Advertisement